The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Editas Medicine Inc’s current trading price is -77.12% away from its 52-week high, while its distance from the 52-week low is -0.93%. The stock’s price
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a loss of -69.20%.However, over the last six months, we can see a
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Editas Medicine Inc’s current trading price is -67.84% away from its 52-week high, while its distance from the 52-week low is 29.21%. The stock’s price
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -67.32% this year. Over the last six months, there has been
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Editas Medicine Inc’s current trading price is -73.31% away from its 52-week high, while its distance from the 52-week low is -0.32%. The stock’s
Editas Medicine Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $11.69 on 12/06/23, while the lowest price for the same duration was marked at $3.18 on 10/03/24. 52-week price history of EDIT Stock
In the biotechnology industry, tools for diagnosing health problems and mechanisms for treating them are developed. Biotech products typically require a significant amount of research and funding before they are approved by the FDA (Food and Drug Administration). A drug’s profitability is often discovered years
All rights reserved © 2024, Powered By Smart TechOne
